This week saw significant funding rounds across various sectors, with notable investments in enterprise software, blockchain, and biotech.
NinjaOne, an enterprise software company specializing in IT operations, led the week with a substantial $400 million in Series C extension funding, bringing its valuation to $12.3 billion. The company reported a remarkable 70% revenue growth in 2025 and achieved profitability in the first quarter of this year. Following closely, Digital Asset, a blockchain technology provider for financial institutions, secured $355 million, bolstered by investments from Andreessen Horowitz's crypto fund.
In the biotech sector, Beren Therapeutics raised $300 million to develop treatments for cholesterol-related conditions, while City Therapeutics garnered $99.5 million for its RNA interference medicines. Meanwhile, TensorWave, focusing on AI cloud infrastructure, raised $350 million to enhance its capabilities in training and inference workloads.
This influx of funding underscores a robust interest in technology-driven solutions within the life sciences and healthcare sectors. As companies like Beren Therapeutics and City Therapeutics attract significant investments, it highlights the growing momentum in biotech innovation, which is crucial for addressing complex health challenges. The trend suggests that investors are increasingly recognizing the potential of AI and advanced technologies to transform healthcare delivery and outcomes.